DAX23.630 -1,5%ESt505.326 -1,8%Top 10 Crypto14,67 +0,8%Dow41.603 -0,6%Nas18.737 -1,0%Bitcoin94.312 -0,5%Euro1,1367 ±0,0%Öl65,03 +1,6%Gold3.360 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 RENK RENK73 BYD A0M4W9 Apple 865985 Tesla A1CX3T Siemens Energy ENER6Y BASF BASF11 Mercedes-Benz Group (ex Daimler) 710000 Allianz 840400 D-Wave Quantum A3DSV9 Deutsche Bank 514000 Lufthansa 823212 Infineon 623100 Deutsche Telekom 555750
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Börsen gehen mit Verlusten ins Wochenende -- DAX geht weit unter 24.000er-Marke ins Wochenende -- IonQ und D-Wave im Blick -- Meta, Apple, Reddit, Amazon, Rheinmetall im Fokus
Top News
US Steel und Nippon Steel: Trump stellt "Partnerschaft" in Aussicht US Steel und Nippon Steel: Trump stellt "Partnerschaft" in Aussicht
Keine Verhandlungslust: Trump will vorerst keine Zoll-Einigung mit der EU Keine Verhandlungslust: Trump will vorerst keine Zoll-Einigung mit der EU
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Pacific Biosciences of California Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
0,8100 EUR -0,0325 EUR -3,86 %
FSE
0,9200 USD -0,0001 USD -0,01 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.243,35 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1C3EQ

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS69404D1081

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolPACB

Pacific Biosciences of California Aktien News

DatumMeistgelesen
PR NewswirePacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications
PR NewswirePacBio Announces Third Quarter 2023 Financial Results
PR NewswirePacBio Announces Appointment of David Meline to Board of Directors
PR NewswirePacBio to Report Third Quarter 2023 Financial Results on October 30, 2023
PR NewswirePacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis
PR NewswirePacBio Announces PacBio Capital
PR NewswirePacBio Announces Collaboration with Leading Library Preparation Automation Partners
PR NewswirePacBio to Present at Upcoming Investor Conferences
PR NewswirePacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
PR NewswirePacBio Reports Equity Incentive Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4)
PR NewswirePacBio Announces Second Quarter 2023 Financial Results
PR NewswirePacBio Enters into Agreement to Acquire Apton Biosystems to Accelerate the Development of a Next Generation, High Throughput, Short-read Sequencer
PR NewswirePacBio Begins Commercialization of the Onso Short-Read Sequencing System
PR NewswirePacBio to Report Second Quarter 2023 Financial Results on August 2, 2023
PR NewswirePacBio's Revio System Empowers Bioscientia to Scale Long-Read Whole Genome Sequencing and Unravel the Mysteries of Rare Disease
PR NewswirePacBio and Radboud University Medical Center Team Up for New Discoveries in Rare Disease Research
PR NewswirePacBio Announces the Appointment of Olga Troyanskaya from Princeton University to the Scientific Advisory Board
PR NewswirePacBio to Present at Upcoming Investor Conferences
PR NewswirePacBio to Present at BofA Securities 2023 Health Care Conference
PR NewswirePacBio Announces Record Revenue in First Quarter 2023
PR NewswirePacBio to Report First Quarter 2023 Financial Results on May 2, 2023
PR NewswirePacBio Announces New Nanobind Extraction Kits to Enable High-Throughput Workflows with Revio and Sequel Systems
PR NewswirePacBio and Corteva Agriscience Enable Groundbreaking Plant and Microbial Long-Read Sequencing Workflow on Revio System
PR NewswirePacBio Announces a New Informatics Analysis Method for Highly Homologous Genes
PR NewswirePacBio To Begin Commercial Shipment of Revio Systems
PR NewswirePacBio to Present at Cowen's 43rd Annual Health Care Conference
PR NewswirePacBio Announces Fourth Quarter and Fiscal Year 2022 Financial Results
PR NewswirePacBio to Expand MAS-Seq Technology to 16S rRNA and Bulk RNA-Seq Solutions
PR NewswirePacBio to Report Fourth Quarter and Full Year 2022 Financial Results on February 16, 2023
PR NewswirePacBio Celebrates Nature Methods Naming Long-Read Sequencing "Method of the Year"
PR NewswirePacBio Announces Record Orders, Including Orders for 76 Revio Systems Received in the Fourth Quarter of 2022
PR NewswirePacBio and the University of Tokyo Announce Bioinformatics Applications Collaboration
PR NewswirePacBio to Present at 41st Annual J.P. Morgan Healthcare Conference
PR NewswirePacBio to Present at Upcoming Investor Conferences
PR NewswirePacBio Announces Third Quarter 2022 Financial Results
PR NewswirePacBio Announces that Euan Ashley, M.D., Ph.D., Joseph Puglisi, Ph.D., and Jay Shendure, Ph.D., Join Newly Created Scientific Advisory Board
PR NewswirePacBio Announces Revio, a Revolutionary New Long Read Sequencing System Designed to Provide 15 Times More HiFi Data and Human Genomes at Scale for Under $1,000
PR NewswirePacBio Announces Onso, the Highly Accurate Short-Read Sequencing Platform
PR NewswirePacBio to Report Third Quarter Earnings on November 7 and Host Inaugural Investor Day on November 15
PR NewswirePacBio Launches Single-Cell Transcriptome Solution Ushering in a New Era of RNA Discovery
Wer­bung

Pacific Biosciences of California News

Pacific Biosciences of California News: auf dieser Seite finden Sie alle Pacific Biosciences of California News und Nachrichten zur Pacific Biosciences of California Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Pacific Biosciences of California News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Pacific Biosciences of California News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.